- Home
- NE vs TLX Comparison
NE vs TLX Comparison
Compare NE & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NE
- TLX
- Stock Information
- Founded
- NE 1985
- TLX 2015
- Country
- NE United States
- TLX Australia
- Employees
- NE N/A
- TLX N/A
- Industry
- NE Other Specialty Stores
- TLX Biotechnology: Pharmaceutical Preparations
- Sector
- NE Consumer Discretionary
- TLX Health Care
- Exchange
- NE Nasdaq
- TLX Nasdaq
- Market Cap
- NE 3.5B
- TLX 3.2B
- IPO Year
- NE N/A
- TLX N/A
- Fundamental
- Price
- NE $28.59
- TLX $9.06
- Analyst Decision
- NE Buy
- TLX Strong Buy
- Analyst Count
- NE 8
- TLX 3
- Target Price
- NE $33.14
- TLX $22.33
- AVG Volume (30 Days)
- NE 1.7M
- TLX 234.3K
- Earning Date
- NE 11-04-2025
- TLX 01-01-0001
- Dividend Yield
- NE 6.94%
- TLX N/A
- EPS Growth
- NE N/A
- TLX N/A
- EPS
- NE 1.94
- TLX 0.04
- Revenue
- NE $3,290,137,000.00
- TLX $664,225,558.00
- Revenue This Year
- NE $15.25
- TLX N/A
- Revenue Next Year
- NE N/A
- TLX N/A
- P/E Ratio
- NE $14.87
- TLX $212.01
- Revenue Growth
- NE 28.85
- TLX 55.35
- 52 Week Low
- NE $17.40
- TLX $8.93
- 52 Week High
- NE $37.99
- TLX $30.36
- Technical
- Relative Strength Index (RSI)
- NE 55.55
- TLX 28.25
- Support Level
- NE $27.53
- TLX $8.93
- Resistance Level
- NE $29.36
- TLX $12.58
- Average True Range (ATR)
- NE 0.96
- TLX 0.46
- MACD
- NE 0.12
- TLX -0.15
- Stochastic Oscillator
- NE 75.63
- TLX 3.54
About NE Noble Corporation plc A
Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and the deployment of its drilling rigs in oil and gas basins around the world.
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.